Welcome to our dedicated page for Nano Labs SEC filings (Ticker: NA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Nano Labs Ltd (NA) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer. Nano Labs files annual reports on Form 20-F and current reports on Form 6-K, which are used to furnish press releases, unaudited consolidated financial statements, and management’s discussion and analysis of financial condition and results of operations.
Recent Form 6-K filings incorporate by reference a range of documents into Nano Labs’ effective Form F-3 shelf registration statements. These include press releases on Web 3.0 infrastructure initiatives, crypto-asset reserve strategies involving BNB and BTC, share repurchase programs, at-the-market equity offerings, uplisting to the Nasdaq Global Market, and early repayment of convertible bonds. One Form 6-K also furnishes unaudited consolidated financial statements and related MD&A, along with Inline XBRL instance and taxonomy extension documents.
Through these filings, investors can track how Nano Labs describes its role as a Web 3.0 infrastructure and product solution provider, a fabless IC design company focused on HTC and HPC chips, and a participant in the crypto assets space. The filings also document changes to share structure, voting rights, and amendments to its memorandum and articles of association approved at shareholder meetings.
On Stock Titan, Nano Labs filings are updated as they are made available on EDGAR, and AI-powered summaries can help explain the contents of lengthy reports. Users can quickly see which filings relate to capital raising under Form F-3, which provide financial statements and MD&A, and which furnish key press releases that outline strategic directions in computing power and Web 3.0.
Nano Labs is offering 5,952,381 Class A ordinary shares at $8.40 per share to institutional investors, along with warrants in a concurrent private placement. The warrants allow purchase of up to 5,952,381 additional shares at $10.00 per share, exercisable for 5 years.
Key offering details:
- Total gross proceeds: $50 million
- Placement Agent (Maxim Group) fee: 7% ($3.5 million)
- Net proceeds before expenses: $46.5 million
- Current stock price: $11.47 (as of June 26, 2025)
Important disclosures: The company operates through subsidiaries in China and Hong Kong, presenting unique risks. As a Cayman Islands holding company, investors don't directly hold equity in Chinese operations. The filing notes PCAOB inspection requirements, Chinese regulatory oversight risks, and potential delisting concerns under HFCAA. Cross-border fund transfers must comply with PRC regulations, with specific procedures for moving capital between subsidiaries.
Nano Labs Ltd (Nasdaq: NA) filed a Form 6-K to announce the pricing of a $50 million capital raise that combines (1) a registered direct offering of 5,952,381 Class A ordinary shares and (2) a concurrent private placement of warrants to purchase an equal number of shares. Each share-and-warrant unit is priced at $8.40, implying gross proceeds of roughly $50 million before placement fees and other transaction costs. The warrants become immediately exercisable, carry a five-year term from the effective registration date, and feature an initial exercise price of $10.00 per share, subject to standard anti-dilution adjustments.
Use of proceeds: Management states that net proceeds—together with any future cash generated from warrant exercises—will be deployed to acquire BNB (Binance Coin) as part of Nano Labs’ evolving digital-asset treasury strategy. No other operational or balance-sheet purposes were disclosed, suggesting a targeted move to increase exposure to cryptocurrency-denominated reserves rather than to fund working capital or R&D.
Structure & timing: The equity component is issued under the Company’s existing shelf registration statement (Form F-3 No. 333-273968), declared effective on 1 Sep 2023. The warrants and the ordinary shares issuable upon exercise are offered privately under Section 4(a)(2) and Regulation D and therefore remain unregistered. Closing is expected on or about 27 Jun 2025, subject to customary conditions. Maxim Group LLC serves as sole placement agent; its fees were not quantified.
Capital-market implications: Immediate dilution will equal the new share count issued (~5.95 million), plus potential future dilution should warrants be exercised. Based on typical free-float data for Nano Labs, the new issuance appears material, although the company did not disclose percentage dilution. The $1.60 spread between the unit price and the $10.00 strike offers investors potential upside yet limits immediate exercise likelihood, thereby postponing secondary dilution and cash inflow.
Strategic context: The decision to convert fresh capital directly into BNB marks an aggressive expansion of the firm’s Web 3.0 centric balance-sheet strategy. While alignment with its infrastructure focus could enhance ecosystem synergy, it also raises crypto-volatility risk and subjects treasury assets to market swings, regulatory scrutiny, and counter-party considerations relating to Binance.
Key takeaways for investors: (1) Nano Labs secures $50 million in near-term liquidity but at the cost of share dilution; (2) proceeds earmarked exclusively for a single crypto asset amplify financial-performance variability; (3) warrant terms could inject an additional $59.5 million (5.95 m × $10.00) of cash if exercised, contingent on future share-price appreciation.